Indian Journal of Obstetrics and Gynecology Research

Print ISSN: 2394-2746

Online ISSN: 2394-2754

CODEN : IJOGCS

Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

Article type

Short Communication


Article page

224- 226


Authors Details

Juhi Deshpande, Chanchal Kumar Singh*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 569

PDF Downloaded: 229


Emsella: A breakthrough, non invasive technology for treatment of incontinence


Short Communication

Author Details : Juhi Deshpande, Chanchal Kumar Singh*

Volume : 10, Issue : 2, Year : 2023

Article Page : 224-226

https://doi.org/10.18231/j.ijogr.2023.047



Suggest article by email

Get Permission

Abstract

Emsella is a revolutionary, US FDA approved, noninvasive treatment technology used for treatment of urinary incontinence in both men and women. It uses High-Intensity Focused Electromagnetic (HIFEM) technology as well as biofeedback mechanism for this purpose. Emsella delivers around 11,000 Kegel’s contractions in half hour and strengthens the muscles so that patients can hold the bladder and urethra together tighter, providing control and strength.Other uses involve sexual rejuvenation, treatment of erectile dysfunction, prolapse, coccydynia.
 

Keywords: Emsella, HIFEM, Stress incontinence, Urge incontinence.


How to cite : Deshpande J, Singh C K, Emsella: A breakthrough, non invasive technology for treatment of incontinence. Indian J Obstet Gynecol Res 2023;10(2):224-226

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.